To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients
出版年份 2022 全文链接
标题
To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients
作者
关键词
-
出版物
Hematology-American Society of Hematology Education Program
Volume 2022, Issue 1, Pages 506-514
出版商
American Society of Hematology
发表日期
2022-12-10
DOI
10.1182/hematology.2022000403
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Thromboprophylaxis in Patients with COVID-19. A Brief Update to the CHEST Guideline and Expert Panel Report
- (2022) Lisa K. Moores et al. CHEST
- Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials
- (2022) Alex C. Spyropoulos et al. CIRCULATION
- Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
- (2022) Geoffrey D Barnes et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
- (2021) Renato D Lopes et al. LANCET
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
- (2021) Eduardo Ramacciotti et al. LANCET
- Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
- (2021) Gary E. Raskob et al. Journal of the American Heart Association
- Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
- (2021) Alex C. Spyropoulos et al. JAMA Internal Medicine
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hospitalized COVID-19 Patients and Venous Thromboembolism
- (2020) Alex C. Spyropoulos et al. CIRCULATION
- Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective
- (2020) Alex C. Spyropoulos et al. THROMBOSIS AND HAEMOSTASIS
- Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration
- (2020) Tobias Tritschler et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Serum and urinary metabolomics and outcomes in cirrhosis
- (2019) Jasmohan S. Bajaj et al. PLoS One
- Extended thromboprophylaxis with betrixaban: a new standard for acute medically ill patients
- (2018) Alexander T Cohen EUROPEAN HEART JOURNAL SUPPLEMENTS
- Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial
- (2018) C. Gibson et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy
- (2017) C. Michael Gibson et al. Journal of the American Heart Association
- Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill PatientsClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
- (2016) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial
- (2014) A. T. Cohen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
- (2013) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population
- (2013) Charles E. Mahan et al. THROMBOSIS RESEARCH
- Introduction to the Ninth Edition
- (2012) Gordon H. Guyatt et al. CHEST
- Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE
- (2011) Alex C. Spyropoulos et al. CHEST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now